Xolair 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26FSBD5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,392
Award facts
- Contract value 100% obligated
- $11,392.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11.4K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 300 mg/2 mL syringes of Xolair. The delivery order was issued on November 18, 2025, with an ultimate completion date of December 10, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing work at its Park Ridge facility and will deliver this biologic immunosuppressant medication to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The parent IDC, valued at $500M with a completion date of December 31, 2036, authorizes DLA to issue multiple firm fixed-price delivery orders for a comprehensive range of pharmaceuticals and medical consumables to support military healthcare facilities worldwide. The vendor's established performance across numerous prior delivery orders and its designation as a regional prime vendor under this strategic initiative position it as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSBD5?
SPE2DR26FSBD5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FSBD5 worth?
The government has obligated $11,392 on SPE2DR26FSBD5.
Is contract SPE2DR26FSBD5 an order under another contract?
Yes. SPE2DR26FSBD5 is a delivery order under SPE2DR25D9311, an indefinite delivery contract.
Was contract SPE2DR26FSBD5 competed?
The extent of competition for SPE2DR26FSBD5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award